PARP inhibitors attenuate chemotherapy-induced painful neuropathy-Reference-Cited by-同舟云学术

PARP inhibitors attenuate chemotherapy-induced painful neuropathy

Published:2012-09 Issue:3 Volume:17 Page:324-330
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:

Author:

Brederson Jill-Desiree,Joshi Shailen K.,Browman Kaitlin E.,Mikusa Joseph,Zhong Chengmin,Gauvin Donna,Liu Xuesong,Shi Yan,Penning Thomas D.,Shoemaker Alex R.,Giranda Vincent L.

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1529-8027.2012.00413.x/fullpdf

Reference41 articles.

1. Interventions for preventing neuropathy caused by cisplatin and related compounds.;Albers;Cochrane Database Syst Rev,2011

2. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections.;Authier;Exp Neurol,2003

3. Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation.;Catalgol;Free Radic Biol Med,2010

4. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.;Cavaletti;Eur J Cancer,2001

5. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.;Cavaletti;Exp Neurol,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future;Ageing Research Reviews;2023-11

2. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities;Neurobiology of Disease;2023-10

3. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids;Current Pharmaceutical Design;2023-02

4. NAD+ metabolism in peripheral neuropathic pain;Neurochemistry International;2022-12

5. Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases;Frontiers in Medicine;2022-11-10